Pharming Group (Pharming Group) Cyclically Adjusted PS Ratio : 3.57 (As of Jun. 20, 2024)

View and export this data going back to . Start your Free Trial

What is Pharming Group Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Pharming Group's current share price is $0.9286. Pharming Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.26. Pharming Group's Cyclically Adjusted PS Ratio for today is 3.57.

The historical rank and industry rank for Pharming Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

PHGUF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.37 Med: 7.9 Max: 22
Current: 3.41

During the past years, Pharming Group's highest Cyclically Adjusted PS Ratio was 22.00. The lowest was 3.37. And the median was 7.90.

PHGUF's Cyclically Adjusted PS Ratio is ranked better than
60.79% of 505 companies
in the Biotechnology industry
Industry Median: 5.3 vs PHGUF: 3.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pharming Group's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.085. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.26 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation

Pharming Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pharming Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Cyclically Adjusted PS Ratio Chart

Pharming Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

14.60

10.04

5.15

6.10

4.99

Pharming Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															6.69	5.67	6.09	4.99	4.69

Competitive Comparison of Pharming Group's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Pharming Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharming Group's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pharming Group's Cyclically Adjusted PS Ratio falls into.

Pharming Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pharming Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio	=	Share Price	/	Cyclically Adjusted Revenue per Share
	=	0.9286	/	0.26
	=	3.57

Pharming Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pharming Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Mar. 2024 (Change)	*	Current CPI (Mar. 2024)
	=	0.085	/	128.5800	*	128.5800
	=	0.085

Current CPI (Mar. 2024) = 128.5800.

Pharming Group Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201406	0.004	99.240	0.005
201409	0.003	99.960	0.004
201412	0.051	99.050	0.066
201503	0.004	99.750	0.005
201506	0.010	100.230	0.013
201509	0.007	100.500	0.009
201512	0.006	99.730	0.008
201603	0.006	100.310	0.008
201606	0.008	100.260	0.010
201609	0.009	100.570	0.012
201612	0.015	100.710	0.019
201703	0.034	101.440	0.043
201706	0.038	101.370	0.048
201709	0.061	102.030	0.077
201712	0.071	101.970	0.090
201803	0.053	102.470	0.067
201806	0.051	103.100	0.064
201809	0.067	103.950	0.083
201812	0.064	103.970	0.079
201903	0.059	105.370	0.072
201906	0.075	105.840	0.091
201909	0.069	106.700	0.083
201912	0.079	106.800	0.095
202003	0.071	106.850	0.085
202006	0.066	107.510	0.079
202009	0.079	107.880	0.094
202012	0.086	107.850	0.103
202103	0.066	108.870	0.078
202106	0.057	109.670	0.067
202109	0.066	110.790	0.077
202112	0.079	114.010	0.089
202203	0.067	119.460	0.072
202206	0.067	119.050	0.072
202209	0.079	126.890	0.080
202212	0.077	124.940	0.079
202303	0.066	124.720	0.068
202306	0.082	125.830	0.084
202309	0.094	127.160	0.095
202312	0.093	126.450	0.095
202403	0.085	128.580	0.085

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Pharming Group (OTCPK:PHGUF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Pharming Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pharming Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group (Pharming Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

PHAR:USA PHARM:Netherlands PHARMa:UK 0QCO:UK PHGN:Germany PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.